Annolyse
BriefingsCompaniesScreenerInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Screener
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Valuation
  3. Analysis
  4. Chat
  5. Data
  6. Sources
←Back to briefings
Savor (SVR) / FY24

NPAT flipped positive on 122.7% tax rate while PBT loss widened 22.5%

EBITDA rose 68.1% on 18.1% revenue growth, but the headline profit reflects an unprecedented tax benefit rather than improvement at the pre-tax line.

Consumer / Hospitality

SVR revenue trajectory

Revenue context before the current result.

↗
Loading chart...
HY24 was $29.1m, versus $20.7m in HY23.

SVR EBITDA margin

EBITDA margin across covered periods.

↗
Loading chart...
  • HY22 SVR HY: Outside range high ebitda margin. 12.3%; 3-period range 6.8% to 10.7%. EBITDA margin: 12.3%, above normal range; 3-period mean 8.1%, range 6.8%-10.7%.
  • HY23 SVR HY: Outside range low ebitda margin. 6.8%; 3-period range 6.9% to 12.3%. EBITDA margin: 6.8%, below normal range; 3-period mean 10.0%, range 6.9%-12.3%.
  • FY22 SVR FY: Outside range low ebitda margin. 9.8%; 5-period range 10% to 14.5%. EBITDA margin: 9.8%, below normal range; 5-period mean 12.4%, range 10.0%-14.5%.
EBITDA margin: 9.8%, below normal range; 5-period mean 12.4%, range 10.0%-14.5%.

SVR operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
HY24 was $2.5m, versus $1.6m in HY23.

SVR working-capital movement

Operating working-capital absorption or release by reporting period.

↗
Loading chart...
  • HY21 SVR: Outside range low operating working-capital movement. $-8m; 3-period range $-1m to $0.2m. Operating working-capital movement: NZ$-8.0m, below normal range; 1/3 prior periods had builds averaging NZ$0.2m, and 1 had releases averaging NZ$-1.0m.
  • FY22 SVR: Outside range high operating working-capital movement. $0.2m; 5-period range $-3.4m to $0.1m. Operating working-capital movement: NZ$0.2m, above normal range; 1/5 prior periods had builds averaging NZ$0.1m, and 4 had releases averaging NZ$-1.8m.
  • FY23 SVR: Unprecedented low operating working-capital movement. $-3.4m; 5-period range $-3.1m to $0.2m. Operating working-capital movement: NZ$-3.4m, unprecedented low; 2/5 prior periods had builds averaging NZ$0.2m, and 3 had releases averaging NZ$-1.2m.
  • HY24 SVR: Outside range high operating working-capital movement. $0.2m; 3-period range $-8m to $0m. Operating working-capital movement: NZ$0.2m, above normal range; 0/3 prior periods had builds, and 2 had releases averaging NZ$-4.5m.
Operating working-capital movement: NZ$0.2m, above normal range; 0/3 prior periods had builds, and 2 had releases averaging NZ$-4.5m.

Market context

Valuation

A close-dated read on what the market price implies next to the latest verified filing inputs. Unavailable metrics stay visible when the absence is useful context.

Prices as at close, 8 June 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$13.1m

i

End-of-day close multiplied by current shares on issue.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

10.1x

i

Recent market cap compared with trailing earnings.

EPS

0.02

i

Recent filing-derived earnings per share.

PEG

Not available

i

Not available for this company right now.

EV/EBITDA

2.43x

i

Enterprise value compared with recent EBITDA.

P/FCF

2.84x

i

Market cap compared with recent free cash flow.

P/B

0.7x

i

Market value compared with latest reported equity.

Income and fund shape

Yield and fund-style valuation where the company shape supports it.

Dividend yield

0.0%

i

Trailing dividends compared with the latest close.

Total return

Not available

i

Available once dividend and adjustment data are verified.

Release date
22 May 2024
Published
23 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Valuation
  3. Analysis
  4. Chat
  5. Data
  6. Sources

Key metrics

Numbers worth scanning first

FY24 vs FY23

Revenue

$61.9m

+18.1% ↑ vs $52.4m

EBITDA

$8.8m

+68.1% ↑ vs $5.2m

Net profit after tax

$0.7m

+130.4% ↑ vs −$2.3m

Net cash inflow from operating activities

$6.4m

+5.5% ↑ vs $6.1m

Final dividend per share

−8.0c

+38.5% ↑ vs −13.0c

Profit before tax

−$2.9m

-26.1% ↓ vs −$2.3m

Total assets

$53.8m

-4.7% ↓ vs $56.4m

What changed

The headline NPAT turnaround is misleading

NPAT moved to +$0.7m from -$2.3m (+127.8%), but profit before tax actually deteriorated to -$2.9m from -$2.3m, a -22.5% movement. The reconciling item is an unprecedented 122.7% effective tax rate versus 0.0% in the prior period, which the historical baseline classifies as an unprecedented high (4-period mean 4.3%, range 0.0%–16.1%).

Above the tax line, the operating picture improved. Revenue grew 18.1% to $61.9m and EBITDA rose 68.1% to $8.8m, lifting EBITDA margin to 14.2% — above the historical baseline range (4-period mean -29.7%). Net debt fell to $9.1m and net debt / EBITDA halved to 1.0x from 2.2x. Cash conversion (OCF / EBITDA) fell to 73.0% from 116.2%.

What matters

Reported profit hinges on a tax credit, not pre-tax progress

  • Despite EBITDA growing $3.6m, depreciation, amortisation and interest still produced a wider pre-tax loss. Treating PBT as the cleaner operating read, the business remained loss-making at the pre-tax line and the headline NPAT depends on a non-cash tax benefit that the historical baseline says is unprecedented.

  • EBITDA margin expansion looks structural. A 14.2% EBITDA margin sits above the supplied historical range (max 12.8%), and management commentary cites roughly four percentage points of margin improvement from cost control. This is the most genuinely durable element of the result.

  • FCF improvement is partly a capex-normalisation effect. Capex collapsed 88.9% to $0.5m (0.8% of revenue) from $4.3m (8.2% of revenue) the prior year. Pre-lease FCF of $5.9m therefore exceeds the historical range, but operating cash flow itself only grew 5.5% to $6.4m. The cash story is real but smaller than the FCF figure suggests.

Expectations

Earlier guidance pointed to EBITDA near the top of range and NPAT of $1.5–$2.0m before one-offs

EBITDA at $8.8m delivered against the upper-bound EBITDA frame; reported NPAT of $0.7m sits well below the NPAT range, with management's $1.9m "before one-off items" figure landing within guidance. The HY24 split implies a second-half-weighted shape (HY24 was only 35.8% of full-year EBITDA, -64.8% of NPAT).

No FY25 targets are supplied in the release excerpts, so forward read-through is limited. The relevant uncertainty is whether margin gains hold once the tax tailwind reverses and capex normalises upward.

Quality of result

The result is bifurcated

The EBITDA, margin, and leverage moves are durable: 14.2% EBITDA margin is above the historical range, gross borrowings fell $2.3m, and net debt / EBITDA halved. ROE of 3.6% is also above the historical range (4-period mean -27.5%). These are genuine improvements in the underlying economics.

The lower-quality elements sit around them. Cash conversion at 73.0% is at the lower edge of the historical range (mean 80.9%), and FCF / NPAT of 911.5% is mathematically inflated by the small NPAT denominator. The pre-lease FCF improvement leans more on capex stepping down ~$3.8m than on operating cash, which only added $0.3m. Working capital release was small in absolute terms ($0.5m), even with debtor days falling to 0.6 and inventory down 12.7%. And the 122.7% effective tax rate — flagged as unprecedented in the historical baseline — is by definition unlikely to repeat at this magnitude.

Unresolved

Open questions

What specifically drove the 122.7% effective tax rate, and how much of that benefit is non-recurring?
Why did capex fall 88.9% to $0.5m, and what is the maintenance-capex level required to sustain the asset base?
Can the 14.2% EBITDA margin be held in FY25 once cost-control phasing normalises?
How does management reconcile the $1.9m "before one-offs" NPAT with the $0.7m reported figure, and which one-offs sit between them?
What FY25 EBITDA and NPAT framing should investors anchor to given no forward targets are disclosed in this release?

This briefing cannot assess the composition of the tax line, the true replacement-capex requirement, or forward-period earnings guidance not supplied in the release.

Chat

Ask about SVR FY24

Ask follow-up questions about Savor's FY24 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about SVR FY24

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Savor's FY24 result.

What specifically drove the 122.7% effective tax rate, and how much of that benefit is non-recurring?Why does "Reported profit hinges on a tax credit, not pre-tax progress" matter?How strong was the cash and earnings quality in FY24?What should I watch next for SVR after FY24?

Checking account...

Data appendix

Show segment detail

Open to load segment breakdown.

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

Savor Annual Report 2024

FY24 / financial report↗

Savor Annual Results - Market Announcement

FY24 / results release↗

Savor Annual Results - NZX Appendix 2

FY24 / results announcement↗

Prior comparable period

Savor Annual Report 2023

FY23 / financial report↗

Savor Annual Results - Market Announcement

FY23 / results release↗

Savor Annual Results - NZX Appendix 2

FY23 / results announcement↗

Interim context

Savor Interim Financial Statements

HY24 / financial report↗

Savor Interim Results Announcement

HY24 / results announcement↗

Savor Interim Results Announcement

HY24 / results release↗

Release context

Savor Market Announcement - Earnings Guidance & Banking Partner

FY24 / commentary↗

Related insights

Cross-company views selected from the metrics in this briefing.

Cash conversion quality

This result converted 73.0% of EBITDA to operating cash flow, -43.2pp versus the prior comparable period.

→

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 150.3pp, with a distortion flag in the result.

→

ROE and capital efficiency

ROE was 3.6%, +18.3pp versus the prior comparable period.

→

Revenue growth context

Revenue growth was 18.1% for this reporting period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when SVR publishes next

Get the next Savor briefing and related NZX reporting-season updates by email.